Elicio Therapeutics, Inc. Depreciation in USD from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Elicio Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q3 2025.
  • Elicio Therapeutics, Inc. Depreciation for the quarter ending September 30, 2025 was $100K.
  • Elicio Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2025 was $392K.
  • Elicio Therapeutics, Inc. annual Depreciation for 2024 was $321K, a 16% decline from 2023.
  • Elicio Therapeutics, Inc. annual Depreciation for 2023 was $382K, a 2.05% decline from 2022.
  • Elicio Therapeutics, Inc. annual Depreciation for 2022 was $390K, a 329% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Elicio Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $392K $100K +$100K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $292K $100K $0 0% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $292K $53K -$29K -35.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $321K $139K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 $100K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $82K -$28K -25.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q3 2023 $0 -$100K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q1 2023 $110K +$78K +244% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $100K +$77K +335% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q1 2022 $117K $32K +$26K +433% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $91K $39K +$62K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $29K $23K -$24K -51.1% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $53K $23K -$24K -51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $77K $6K -$21K -77.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $98K -$23K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $47K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $47K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $27K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17

Elicio Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $321K -$61K -16% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $382K -$8K -2.05% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $390K +$299K +329% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $91K -$7K -7.14% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $98K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.